Wilkinson Global Asset Management LLC Amgen Inc Transaction History

Wilkinson Global Asset Management LLC

$1.54 Billion
Q3 2025

A detailed history of Wilkinson Global Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Wilkinson Global Asset Management LLC holds 218,364 shares of AMGN stock, worth $74.6 Million. This represents 4.01% of its overall portfolio holdings.

Number of Shares

218,364

Previous 253,635 13.91%

Holding current value

$74.6 Million

Previous $70.8 Million 12.98%

% of portfolio

4.01%

Previous 4.62%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	SELL	$271.18 - $309.22 $9.56 Million - $10.9 Million	-35,271 Reduced 13.91%	218,364 $61.6 Million
Q2 2025 Aug 11, 2025	SELL	$262.28 - $309.85 $5.93 Million - $7.01 Million	-22,612 Reduced 8.19%	253,635 $70.8 Million
Q1 2025 May 01, 2025	SELL	$258.59 - $327.36 $739,050 - $935,594	-2,858 Reduced 1.02%	276,247 $86.1 Million
Q4 2024 Jan 31, 2025	SELL	$258.78 - $328.31 $1.57 Million - $2 Million	-6,077 Reduced 2.13%	279,105 $72.7 Million
Q3 2024 Oct 31, 2024	SELL	$309.38 - $337.38 $2.53 Million - $2.76 Million	-8,187 Reduced 2.79%	285,182 $91.9 Million
Q2 2024 Aug 06, 2024	SELL	$262.75 - $319.31 $1.33 Million - $1.61 Million	-5,047 Reduced 1.69%	293,369 $91.7 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $6.58 Million - $7.95 Million	24,484 Added 8.94%	298,416 $84.8 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $60,089 - $67,788	-235 Reduced 0.09%	273,932 $78.9 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $508,361 - $631,144	-2,325 Reduced 0.84%	274,167 $73.7 Million
Q2 2023 Jul 28, 2023	SELL	$214.27 - $253.37 $739,017 - $873,873	-3,449 Reduced 1.23%	276,492 $61.4 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $1.23 Million - $1.49 Million	-5,432 Reduced 1.9%	279,941 $67.7 Million
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $1.88 Million - $2.38 Million	8,194 Added 2.96%	285,373 $75 Million
Q3 2022 Oct 19, 2022	BUY	$224.46 - $253.15 $411,435 - $464,023	1,833 Added 0.67%	277,179 $62.5 Million
Q2 2022 Jul 26, 2022	SELL	$230.71 - $256.74 $1.13 Million - $1.25 Million	-4,880 Reduced 1.74%	275,346 $67 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $6.59 Million - $7.29 Million	30,040 Added 12.01%	280,226 $67.8 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $484,272 - $554,206	2,435 Added 0.98%	250,186 $56.3 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $553,812 - $648,858	-2,609 Reduced 1.04%	247,751 $52.7 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $1.02 Million - $1.14 Million	4,385 Added 1.78%	250,360 $61 Million
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $54.6 Million - $63.6 Million	245,975 New	245,975 $61.2 Million

Others Institutions Holding AMGN

# of Institutions

3,269

Shares Held

428M

Call Options Held

6.17M

Put Options Held

5.85M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $183B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilkinson Global Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilkinson Global Asset Management LLC with notifications on news.

Account

Wilkinson Global Asset Management LLC Amgen Inc Transaction History